LEQEMBI IQLIK(R) (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease JCN Newswire 20:00 Thu, 27 Aug
Leqembi Iqlik Offers At-Home SC Initiation for Early Alzheimer Disease Psychiatry Advisor 16:17 Wed, 26 Aug
Biogen And Eisai Launch Leqembi Iqlik Autoinjector For Early Alzheimer's In U.S. RTT News 14:02 Mon, 24 Aug
Leqembi Iqlik launches in US for early Alzheimer’s PharmaTimes 10:51 Wed, 26 Aug LEQEMBI IQLIK Biotech Pharma
Skyclarys approved: HSE to fund Friedreich’s Ataxia drug for Irish patients JOE.ie 15:41 Tue, 25 Aug Skyclarys Biotech Pharma All sources
Will FDA approve Biogen’s promising new treatment for Alzheimer's? The Independent Institute (Weblog) 14:13 Sun, 23 Aug Pharma Biotech
Biogen expands digital strategy with Veeva Vault CRM RTT News 03:52 Wed, 26 Aug Veeva Vault CRM Biotech Pharma
STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 3d Novartis Pharma Science
STAT Plus: After failure of Angelman syndrome drug, experts see hope in other experimental therapies STAT 3d Pharma
Ionis chalks up CNS win as FDA greenlights Zanvastro in Alexander disease BioWorld 3d Pharma Article paywall
